Cooperative regulation of non-small cell lung carcinoma angiogenic potential by macrophage migration inhibitory factor and its homolog, D-dopachrome tautomerase.
Cooperative regulation of non-small cell lung carcinoma angiogenic potential by macrophage migration inhibitory factor and its homolog, D-dopachrome tautomerase.
复制标题
DOI:
10.4049/jimmunol.181.4.2330
复制
发表时间:
2008-08-15
期刊:
影响因子:
--
通讯作者:
Mitchell RA
中科院分区:
文献类型:
--
作者:
Coleman AM;Rendon BE;Zhao M;Qian MW;Bucala R;Xin D;Mitchell RA
Tumor-derived growth factors and cytokines stimulate neoangiogenesis from surrounding capillaries in order to support tumor growth. Recent studies reveal that macrophage migration inhibitory factor (MIF) expression is increased in lung cancer, particularly non-small cell lung carcinomas (NSCLC). Because MIF has important autocrine effects on normal and transformed cells, we investigated whether autocrine MIF and its only known family member, D-dopachrome tautomerase (D-DT), promote the expression of pro-angiogenic factors CXCL8 and VEGF in NSCLC cells. Our results demonstrate that the expression of CXCL8 and VEGF are strongly reliant upon both the individual and cooperative activities of the two family members. CXCL8 transcriptional regulation by MIF and D-DT appears to involve a signaling pathway that includes the activation of c-Jun-N-terminal Kinase (JNK), c-jun phosphorylation and subsequent AP-1 transcription factor activity. Importantly, human umbilical vein endothelial cell (HUVEC) migration and tube formation induced by supernatants from lung adenocarcinoma cells lacking either or both MIF and D-DT are substantially reduced when compared to normal supernatants. Finally, we demonstrate that the cognate MIF receptor, CD74, is necessary for both MIF and D-DT-induced JNK activation and CXCL8 expression, suggesting its potential involvement in angiogenic growth factor expression. This is the first demonstration of a biological role for D-DT and its synergism with MIF suggests that the combined therapeutic targeting of both family members may enhance current anti-MIF based therapies.
登录
查看更多内容
影响因子:
3.7
作者:
Natarajan, R;Gupta, S;Fowler, AA
通讯作者:
Fowler, AA
DOI:
10.1073/pnas.0701553104
发表时间:
2007-08-14
影响因子:
11.1
作者:
Binsky, Inbal;Haran, Michal;Shachar, Idit
通讯作者:
Shachar, Idit
影响因子:
15.9
作者:
Arenberg, DA;Keane, MP;Strieter, RM
通讯作者:
Strieter, RM
影响因子:
82.9
作者:
Mizukami, Y;Jo, WS;Chung, DC
通讯作者:
Chung, DC
DOI:
10.1152/ajplung.00060.2002
发表时间:
2002-10-01
影响因子:
4.9
作者:
Li, J;Kartha, S;Hershenson, MB
通讯作者:
Hershenson, MB